Journal Club 2: DEXENCEPH Study

We are excited to invite you to the upcoming CLIMB India Journal Club, led by the team from AIIMS Delhi. 🧠 Featured Discussion: DEXENCEPH Study – examining the evidence for adjunctive corticosteroid therapy in Herpes Simplex Virus (HSV) encephalitis Despite antiviral therapy with acyclovir, outcomes in HSV encephalitis remain suboptimal. The DEXENCEPH study explores whether adding steroids could improve neurological outcomes by modulating inflammation. 💡 Join us as we: • Critically appraise the study design and methodology • Discuss clinical implications for neurocritical care • Explore the evolving evidence on immunomodulation in encephalitis